Marina Basina is an Endocrinology/Metabolic physician. OpenAlex indexes 134 publications with 1,787 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 15 Apr 2024.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20253 payments
- Dexcom, Inc.Program year20251 payment
- Medtronic, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
77.1%Insulin Analog24%Lantus Solostar14%Humalog Kwikpen U-10011%Basaglar Kwikpen U-1009%Tresiba Flextouch U-2008%Tresiba Flextouch U-1008%Insulin Aspart Flexpen6%Novolog Flexpen6%Fiasp Flextouch6%Insulin Glargine-Yfgn5%Insulin Lispro Kwikpen U-1005%Toujeo Solostar4%Humalog4%Novolog3%Toujeo Max Solostar2%Humalog Kwikpen U-2002%Fiasp2%Insulin Aspart2%Insulin Lispro2%Levemir Flexpen1%Lantus1%Semglee (Yfgn) Pen1%Part D<11 patientsGLP-1 receptor agonist21.3%Mounjaro36%Ozempic31%Trulicity25%Rybelsus7%Victoza 3-Pak1%Part D<11 patients+ 14 more classes in this area
Hormonal (systemic)
14.3%l-Thyroxine11.2%Levothyroxine Sodium85%Synthroid15%Part D≥148 patientsThyroid Hormone Synthesis Inhibitor0.8%Methimazole100%Part D≥14 patients+ 5 more classes in this area
Cardiovascular
6.9%Statin4.7%Atorvastatin Calcium48%Rosuvastatin Calcium29%Pravastatin Sodium14%Simvastatin9%Part D<11 patientsAngiotensin receptor blocker (ARB)0.9%Losartan Potassium100%Part D≥17 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2006–2026 per NIH RePORTER. The latest:
- The Stanford Clinical Center for the Study of Type 1 Diabetes in Acute Pancreatitis
Stanford University
FY2026$478,000U01DK127395 - The Stanford Clinical Center for the Study of Type 1 Diabetes in Acute Pancreatitis
Stanford University
FY2025$448,500U01DK127395 - The Stanford Clinical Center for the Study of Type 1 Diabetes in Acute Pancreatitis
Stanford University
FY2024$255,390U01DK127395
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”